Overexpression of CYCLIND1 is common in ESCC cell lines and is a poor prognostic marker of poor ESCC outcomes, due to its strong association with increased lymph nodes or distant metastasis, high proliferation rates and poor responses to chemotherapy1. This evidence concerns the gene CCND1 and esophageal squamous cell carcinoma.